Drugs / AT-301B
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04519788 Comparator | Aug → Dec 2020 | — | Atossa Therapeutics, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AT-301B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04519788 ↗ |
| Route | Intranasal | “Nasal Spray” NCT04519788 ↗ |